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Abstract 
The dominant cause of malaria in Malaysia is now Plasmodium knowlesi, a zoonotic parasite of 
cynomolgus macaque monkeys found throughout South East Asia. Comparative genomic analysis of 
parasites adapted to in vitro growth in either cynomolgus or human red blood cells (RBCs) identified 
in parasites growing in cynomolgus RBCs but not human RBCs a genomic deletion that includes the 
gene encoding normocyte binding protein Xa (NBPXa). Experimental deletion of the NBPXa gene in 
parasites adapted to growth in human RBCs (which retain the ability to grow in cynomolgus RBCs) 
restricted them to cynomolgus RBCs, demonstrating that this gene is selectively required for parasite 
multiplication and growth in human RBCs.  NBPXa-null parasites could bind to human RBCs but 
invasion of these cells was severely impaired.  NBPXa is therefore identified as a key mediator of P. 
knowlesi human infection and may be a target for vaccine development against this emerging 
pathogen.  
 
Significance statement 
Plasmodium knowlesi is a parasite that naturally infects cynomolgus monkeys, but is also a major 
cause of severe zoonotic malaria in humans in South East Asia. Comparing the genomes of parasites 
restricted to growth in culture with cynomolgus red blood cells (RBCs) with those adapted to growth 
in human RBCs identified a gene specifically required for invasion of human red blood cells (RBCs), a 
process that is critical for parasite replication. This gene encodes NBPXa, a protein previously shown 
to bind human RBC and implicated in invasion.  Disruption of this gene blocks invasion of human but 
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not cynomolgus RBCs, thus confirming a key mediator of human infection and a potential target for 
inclusion in vaccines to prevent human infection.  
 
\body 
Introduction 
Plasmodium knowlesi, a malaria parasite of the cynomolgus macaque, Macaca fascicularis, is the 
causative agent of severe zoonotic disease in South East Asia (1, 2). In countries such as Malaysia 
where other malaria parasites are being controlled effectively, P. knowlesi infections are the 
dominant cause of human malaria (3, 4). In all malaria parasite species, disease is caused by cyclic 
parasite multiplication within red blood cells (RBCs), releasing invasive merozoites that invade new 
RBCs. Parasite adhesins transported onto the merozoite surface bind specific host cell receptors to 
facilitate RBC invasion (reviewed in (5)). The first adhesin-RBC interaction was identified in P. 
knowlesi and P. vivax, where it was shown that parasites must bind to the Duffy Antigen/Chemokine 
Receptor (DARC) to invade human RBCs (6). These adhesins are determinants of parasite virulence 
(7), host cell tropism (8), and potential vaccine candidates (9), and understanding the role of these 
adhesins may be critical to identifying the causes of increased risk of human infection and for the 
development of novel interventions. 
Reticulocyte binding proteins (RBPs) were first described in Plasmodium vivax (10) and are 
the prototypical examples of the reticulocyte binding like/reticulocyte binding homologue (RBL/RH) 
proteins also characterized in other malaria parasite species including  P. cynomolgi  (11) and P. 
yoelii (12). P. falciparum normocyte binding proteins (NBPs) (13, 14) are members of this family that 
includes four conventional RBL/RH proteins and one unconventional short RBL/RH protein (RH5) in 
this species (reviewed in (5)). In P. knowlesi two proteins in the RBL family known as Normocyte 
Binding Protein (NBP)Xa and NBPXb have  been identified (15), and recombinant fragments of these 
proteins bind RBCs (16).  The RBL/RH adhesins and the Duffy binding protein/erythrocyte binding 
ligand (DBP/EBL) family of proteins, play key roles during merozoite invasion of RBCs (reviewed in (5, 
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9)). However, ascribing specific roles to these proteins has been hampered by functional redundancy 
and only RH5 may be essential for P. falciparum invasion (17). In P. knowlesi, DBPα is the parasite 
adhesin binding DARC, and two paralogues (DBP and DBP) have also been identified (18), but thus 
far only DBP has been shown to be required for RBC invasion (19).    
 P. knowlesi can be readily grown in both cynomolgus and rhesus macaque (Macaca mulatta) 
RBCs in vitro (20-22), but requires extended adaptation for growth in human RBCs  in vitro displaying 
insufficient invasion efficiency in human RBCs to support continuous culture. In previous work we 
overcame this impediment by extended adaptation in a mixture of human and cynomolgus RBCs, 
producing a parasite line that can be maintained in human RBCs alone (21). This previous analysis 
suggested that improved parasite invasion of human RBCs was essential for maintenance of parasite 
growth in vitro. 
 Here, we undertook a comparative analysis of the genomes of P. knowlesi lines adapted to 
human or cynomolgus RBCs in culture, in parallel with that of the pre-adapted parasites. The 
comparison highlighted a crucial role for NBPXa in invasion of human RBCs. Using the unique 
capacity to grow this parasite in two host cell types we were able to disrupt the gene encoding 
NBPXa and show it is required for invasion of human but not cynomolgus macaque RBCs. Human-
adapted P. knowlesi parasites provide a robust experimental platform to unravel mechanisms of 
host cell invasion in both P. knowlesi and the related pathogen Plasmodium vivax. 
 
Results 
Culture adaptation of P. knowlesi is associated with distinct large genomic deletions and 
duplications. To identify genetic changes occurring during adaptation to in vitro culture we 
compared the parasite genomes at two critical points in the process: within 2 months of introducing 
the parasite to culture (A1-O), and after full adaptation to growth in human RBCs (A1-H) or in 
cynomolgus  RBCs (A1-C) for a similar period (see Fig. 1A).  Genome sequence analysis confirmed 
that the starting A1-O parasite is closely related to the H-strain (23, 24). Use of the PacBio 
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sequencing platform allowed the generation of high quality genome assemblies (Table S3) for clones 
of the adapted parasite lines (A1-H.1 and A1-C.2) to use as references to identify SNPs and INDELs 
(insertions/deletions) amongst both the uncloned lines and the other derived clones. Few nucleotide 
differences were identified (Fig. 1A and Table S1), with only 22 non-synonymous variants in protein 
coding genes throughout all lines sequenced. Only three of these differences were found exclusively 
in the human adapted parasite and none was present in all clones, so they were unlikely to be 
responsible for the adaptation phenotype (Table S1). Similarly there were no non-synonymous 
substitutions present in long-term culture adapted lines but absent from the A1-O parasite.  In 
addition to these SNPs, four larger deletions (3.6-66.3 kb) and one duplication (7.7 kb) were 
identified. In contrast to the SNPs, these appeared to be specific to either human or cynomolgus 
adapted lines, resulting in deletion of 13 genes in A1-C derived lines, or deletion of 2 genes and 
duplication of 4 genes in A1-H derived lines (Table S2). The largest deletion was of ~66.3 kb at one 
end of chromosome 14 in the A1-C line (Fig. 1B and Fig S1).  In A1-O and A1-H lines, this region 
encompasses 12 genes (Table S2), including PKNH_1472300 that encodes NBPXa (15). This 
observation was of particular interest as adaptation to human RBCs appeared to result from 
improved invasion efficiency rather than improved intracellular growth (21). The genomic 
comparisons identified no substantial differences in other known invasion gene loci, including DBPα, 
DBPβ, DBPγ and NBPXb genes. Similarly, whilst we detected a duplication in A1-H derived lines, 
which contained 4 genes including GTP cyclohydrolase I, we found no evidence of increased copy 
number for any of the DBP or RBL genes. However, using our data and a set of 48 P. knowlesi 
genomes from malaria infections in Malaysia (25), a high level of SNP diversity can be shown for the 
NBPX and DBP genes (Figure S3, Table S4).   
Adaptation to human RBCs results in increased invasion efficiency for both human and 
cynomolgus RBCs.  The genetic differences between cynomolgus and human RBC-adapted parasite 
lines, including the loss of NBPXa in the A1-C line, suggested that the A1-C and A1-H lines had been 
subjected to distinct selection processes during culture adaptation. Therefore growth of these lines 
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was compared with that of the A1-O line to try to correlate genetic and phenotypic differences (Fig. 
2). To compare invasion efficiencies, schizonts purified from each line grown in cynomolgus RBCs 
were  added to fresh human or cynomolgus RBCs, and then new intracellular parasites were 
quantified 24 h later. The invasion efficiency of the A1-O line in cynomolgus RBCs was around half 
that of both the A1-H.1 and A1-C.1 lines, consistent with selection for improved invasion following 
prolonged culture (Fig. 2A). Further examination of the cultures showed no evidence for defects in 
subsequent intracellular growth (Fig. 2B and C). In human RBCs the invasion efficiency of the A1-O 
line was approximately half that of the A1-H.1 line, but four times that of the A1-C.1 line. Thus, 
whilst the A1-H.1 line increased in invasion efficiency for both human and cynomolgus RBCs during 
more than a year in vitro, A1-C.1 achieved the same only in cynomolgus RBCs, with a reduction in 
invasion efficiency for human RBCs. Using the 24 hour invasion data to calculate a mean host RBC 
selectivity ratio for the different lines (cynomolgus RBC invasion efficiency/human RBC invasion 
efficiency) revealed no significant differences between host cell selectivity of the A1-O and A1-H.1 
lines (cynomolgus selectivity [+/- 1 s.d.] = 1.53 +/-0.14 and 1.54 +/-0.49, respectively), clearly 
demonstrating that no specific increase in human RBC invasion efficiency had occurred in the A1-H.1 
line. In contrast, the selectivity of the A1-C.1 line for cynomolgus RBC had significantly increased 
(cynomolgus selectivity = 16.1+/-8.1) compared to both the A1-H.1 and A1-O lines (1-way ANOVA, 
p=0.0044). The absence of NBPXa in the A1-C.1 line clearly did not reduce its invasion efficiency for 
cynomolgus cells. We therefore reasoned that its loss may have caused the shift in host cell 
selectivity through reduced invasion efficiency for human RBCs. The ability of the A1-H.1 line to grow 
interchangeably in the two host RBCs offered a unique opportunity to test this hypothesis. No other 
clear relationship between genotype and adaptation to culture was established. 
The NBPXa gene can be disrupted in A1-H.1 parasites grown in cynomolgus but not human RBCs. 
To analyse the role of NBPXa, A1-H.1 parasites were transfected with a gene disruption construct 
(Fig. 3A) and maintained under drug selection in either human or cynomolgus RBCs until resistant 
parasites emerged (8-15 days). Analysis of these parasites by PCR revealed successful disruption of 
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NBPXa in parasites from independent transfections maintained in cynomolgus RBCs (n=5) but not in 
parasites grown in human RBCs (n=3), despite successful integration of control plasmid (Fig. 3B). 
Thus, the NBPXa gene appeared to be refractory to disruption in parasites grown in human but not 
cynomolgus RBCs, indicating a host species-specific requirement for this gene. Two independent 
ΔNBPXa cloned lines were derived from A1-H.1 parasite transfections in cynomolgus RBCs and used 
for subsequent phenotypic analysis. 
NBPXa is unnecessary for invasion of cynomolgus RBCs but crucial for invasion of human RBCs. We 
examined the ability of the ΔNBPXa clones to invade and grow within either human or cynomolgus 
RBCs in the 24 hour invasion assay. Disruption of NBPXa had no effect on invasion and growth in 
cynomolgus RBCs, but invasion of human RBCs was significantly impeded, matching the phenotype 
of the A1-C.1 line (Fig. 4A and Fig. S2). Whilst the defect in human RBC invasion caused by loss of the 
NBPXa gene was severe and prevented multiplicative growth, a low frequency of successful 
invasions were detected for both the A1-C.1 and ΔNBPXa lines. To rule out the possibility that this 
was due to contamination of purified schizonts with cynomolgus RBCs, the parasites were allowed to 
invade RBCs pre-labelled with a fluorescent dye (26). The results showed that whilst contaminating 
cynomolgus RBCs contributed to a slight overestimation of invasion efficiency in human RBCs, a 
small fraction of both the ΔNBPXa and A1C.1 parasites was able to infect human RBCs. Parasitemia 
measurements at 48 h showed that the ΔNBPXa human RBC invasion phenotype was expressed in 
subsequent cycles, and the parasite could not undergo multiplicative growth in human RBCs (Fig. 4B 
and C). Extended culture of  ΔNBPXa parasites in human RBCs resulted in a rapid reduction of 
parasitemia consistent with the severe defect. Although some parasites were detectable after 27 
days culture these were revertants, which had deleted the NBPXa disruptant construct (Fig. S2B). 
These data demonstrate the severity of the ΔNBPXa phenotype, accounting for both the inability to 
disrupt the NBPXa gene and the severely reduced growth of the A1-C.1 line in human RBCs.  
Further analysis showed that the ΔNBPXa block occurred within the first 7 h of the assay, 
consistent with a defect in invasion rather than in subsequent intracellular growth (Fig. 4B and C); 
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examination of Giemsa-stained blood smears taken at 7 h showed that whilst A1-H.1 parasites had 
successfully developed as ring stages in human RBCs, most of the ΔNBPXa parasites appeared to be 
extracellular merozoites that had attached to, but not invaded RBCs (Fig. 4D and E). To see whether 
or not this observation was consistent with a phenotype expressed subsequent to RBC binding, we 
used an immunofluorescence-based merozoite surface protein 1 (MSP1) processing assay (27) to 
distinguish merozoites that had successfully invaded and formed rings (MSP119 positive only) from 
those that had attached but failed to invade, (MSP133 and MSP119 double positive) (Fig.5A). Whilst 
92% of A1-H.1 merozoites successfully formed rings in human RBCs, 76% of ΔNBPXa merozoites 
attached but failed to invade human RBCs (Fig 5B). In contrast, about 90% of merozoites from both 
lines successfully formed rings in cynomolgus RBCs (Fig 5B). These results show that NBPXa 
disruption results in a block in invasion following initial merozoite attachment.  
To ensure that up (or down) regulation of another gene was not responsible for the 
observed phenotype, RNA-seq analysis of schizont stages of A1-H.1 and ΔNBPXa parasites was 
performed. This did not identify any significantly differentially expressed genes.  
Deletion of NBPXa does not result in restriction to human reticulocytes.  Previous work by others 
had suggested that the ability to invade and grow in human reticulocytes as well as normocytes is a 
key parasite adaptation to culture in human RBCs (22). Our observation that both the ΔNBPXa and 
A1-C.1 lines invaded a small percentage of human RBCs raised the possibility that loss of NBPXa 
function restricted the parasite to invasion of reticulocytes, which typically constitute 0.5-2% of total 
RBCs. To investigate this possibility, we used an adapted protocol (28, 29) to enrich reticulocytes to 
around 10% of human RBCs and used these cells for invasion assays. Reticulocyte enrichment 
resulted in a small increase in invasion efficiency over normal human RBCs for the A1-O, A1-H.1, A1-
C.1 and ΔNBPXa lines, suggesting that younger RBCs are favoured by all lines (Fig. S2). However, 
these increases were insufficient to explain the ΔNBPXa phenotype as due to reticulocyte restriction. 
Furthermore, the few successfully invaded ΔNBPXa parasites were present in both reticulocytes and 
normocytes. 
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NBPXa is unnecessary for invasion of rhesus RBCs. Disruption of NBPXa had no effect on invasion 
into rhesus RBCs (Fig. S2) although invasion efficiency was significantly higher for cynomolgus RBCs 
than rhesus RBCs for all lines tested (A1-H.1, A1-C.1, and ΔNBPXa), suggesting that the parasite has 
slightly different adhesin specificities even for these closely related hosts, although this difference 
may also be explained by phenotypic culture adaptation to cynomolgus RBCs. 
 
Discussion 
 In this work we set out to identify parasite features that facilitate growth in human RBCs in vitro, 
exploiting P. knowlesi lines that we previously adapted to growth in either human or cynomolgus 
RBCs. Comparative genome analysis of the culture adapted lines revealed relatively few non-
synonymous SNPs and none of these associated universally with either adaptation to human RBCs or 
long-term culture. In contrast, we detected several large genome deletions and a duplication, which 
were present in either human or cynomolgus adapted lines but not both and present in the 
uncloned lines as well as clones derived from them, suggesting that selection had led to fixation 
within the population. Further analysis of these deletions, either by individual gene deletion as we 
have demonstrated for NBPXa, or by gene complementation may be informative. The duplication in 
A1-H derived lines contains the gene coding for GTP cyclohydrolase, a rate limiting enzyme in folate 
metabolism, and duplications of this gene are associated with drug resistance in South East Asian 
strains of P. falciparum (30). Increased activity in this pathway and metabolic adaptation may 
provide a general selective advantage for growth in culture.  
Correct assembly and read mapping for several key gene families, in particular the DBPs, was 
only possible with the use of PacBio sequencing, which produces longer read lengths. Using these 
data as a scaffold to map the higher coverage but shorter Illumina reads facilitated high quality de 
novo assemblies of both A1H.1 and A1-C.2 cloned lines, which complement the existing H-strain data 
and will benefit further work with the culture-adapted P. knowlesi lines.  
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 Our previous comparison of cynomolgus- and human-adapted P. knowlesi parasite lines had 
suggested that an increase in human RBC invasion efficiency enabled the parasite to adapt to long 
term culture in human RBCs (21). However, the additional comparison with the invasion 
characteristics of the A1-O line, which had been in culture for less than 2 months, demonstrated that 
the host cell specificity of the A1-H lines had remained unchanged. Instead the overall invasion 
efficiency for both human and cynomolgus RBCs had improved, with invasion of human RBCs above 
the minimum threshold required to support in vitro multiplication and growth. In contrast, the A1-C 
line (and its derived clones) increased its invasion efficiency only for cynomolgus RBCs. This 
increased selectivity is likely the result of the loss of a section of one end of chromosome 14 
containing the gene for NBPXa which we have demonstrated to be crucial for human RBC invasion. 
Given that the cynomolgus RBC invasion phenotype of both the A1-C.1 and A1-H.1 are 
indistinguishable, it is quite possible that if A1-C parasites had not lost NBPXa, invasion efficiency for 
human RBCs in culture would have risen to levels equivalent to that seen for A1-H.1 without prior 
exposure to human RBCs. In principle this could be investigated by genetic complementation of the 
lost NBPXa gene within the A1-C.1 line, but so far such efforts have been hampered by its large size 
(8.5 kb). The reasons for the different behaviour of the H-strain parasite (which was isolated from a 
patient (23)) in vivo and in vitro are unclear but our results suggest that for successful parasite 
multiplication and survival in vitro, prolonged physiological adaptation to culture is more important 
than adaptation to a specific host RBC. Our data identified clear differences in invasion efficiencies 
into RBCs from rhesus and cynomolgus macaques, which is surprising given that these two primate 
species are  closely related (31) and that experimental infection of rhesus monkeys (not a natural 
host of P. knowlesi) results in hyperparasitemia (23) in contrast to the chronic low-level parasitemia 
characteristic of cynomolgus infection.  Recombinant NBPXb expressed on cells binds cynomolgus 
RBCs four times more effectively than rhesus RBC (16), offering one possible mechanism for this 
difference in invasion efficiency. Independently established culture-adapted parasite strains 
developed using rhesus RBCs (20, 22) may have undergone quite different adaptive changes to those 
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observed for cynomolgus RBCs. It will also be of interest to determine the contribution of metabolic 
adaptation to growth in different RBCs in culture. 
P. knowlesi is phylogenetically closely related to P. vivax (32), a malaria parasite which 
causes the majority of malaria cases outside of Africa and which currently cannot be cultured in 
vitro. Whilst both these parasites use an orthologous DBP to bind to the DARC receptor on host RBCs 
(6, 18, 33, 34), there are greater differences in the RBL family. P. vivax can only invade reticulocytes, 
a phenotype attributed to the presence of RBP1 and RBP2, which bind only to reticulocytes (10), and 
neither of which is conserved in P. knowlesi. Orthologues of the P. knowlesi RBLs are present in P. 
vivax (35, 36), but given that our data indicate the P. knowlesi NBPXa protein is functional in invasion 
of both normocytes and reticulocytes, it is tempting to speculate that the absence of this protein in 
P. vivax could account for the parasite’s reticulocyte restriction. Intriguingly another closely related 
simian malaria parasite, P. cynomolgi, contains orthologues for both vivax and knowlesi specific RBL 
proteins (11, 37). Transferring orthologues from P. vivax or P. cynomolgi into P. knowlesi may offer 
opportunities to study both the requirements for and the evolution of P. vivax invasion. 
The unique advantages of the P. knowlesi culture system have enabled us to demonstrate 
that NBPXa plays a crucial role in invasion of human RBCs. Its role appears to be after initial 
merozoite attachment, perhaps during establishment of the moving junction between RBC and 
parasite plasma membranes which is required for invasion. In other Plasmodium species, both the 
RBL and DBP protein families are highly redundant and ascribing precise roles has been difficult, 
although in P. falciparum they have been implicated in triggering signalling and release of secretory 
organelles (38). The ability to grow P. knowlesi interchangeably in different host cells with distinct 
adhesin requirements enables the generation of lines with gene knockouts for important parasite 
adhesins like NBPXa, providing a powerful and unique opportunity to investigate their precise role in 
red cell invasion.  
In P. knowlesi the adhesin repertoire is smaller than in many malaria parasites (9, 15, 18), 
and loss of either DBPa (6, 19) or NBPXa creates a critical block in invasion of human RBCs, perhaps 
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because the paralogues cannot bind human RBCs; for example whilst PkNBPXa and DBPa proteins 
bind to both human and macaque RBCs,  DBPβ, DBPγ and NBPXb bind only to macaque RBCs (16, 
39). This apparent lack of adhesin redundancy for human RBC invasion suggests that P. knowlesi is 
vulnerable to perturbation of DBPα/NBPXa function. Although this lack of redundancy may  
encourage the use of these antigens in vaccine development their diversity in parasites responsible 
for human infection (25, 40) provides an important caveat. Vaccine development may be an 
important strategy for control of P. knowlesi malaria given the presence of a primate reservoir in 
Southeast Asia. 
NBPXa polymorphisms are important determinants of high parasitemia and disease severity 
in P. knowlesi infection (7) and may impact on the potential for human to human transmission. . 
Given that we have shown a critical role for this protein in human RBC invasion, it is possible that  
increased virulence and multiplication rates of parasites containing particular alleles is due to an 
improved ability to bind and invade human RBCs. However even the human adapted P. knowlesi line 
has a higher efficiency of cynomolgus RBC invasion, suggesting that invasion efficiency may remain a 
bottleneck in human infections.  Interestingly variation in NBPXb, which had been found not to bind 
to human RBCs, has also been linked to disease severity in humans (7, 16). The role of NBPXb and 
variants of both P. knowlesi NBPs can now be investigated in vitro. . Human-adapted P. knowlesi 
parasites provide a robust experimental platform to unravel mechanisms of host cell invasion and 
aid development of strategies to control malaria caused by P. knowlesi and the closely related 
pathogen P. vivax. 
Methods 
Macaque, Human and Reticulocyte-Enriched RBC.  Cynomolgus and rhesus blood was collected by 
venous puncture. Animal work was approved by the United Kingdom Home Office as governed by 
United Kingdom law under the Animals (Scientific Procedures) Act 1986. Human blood (Groups A+ 
and O+; Duffy+) was obtained from the UK National Blood Transfusion service. Reticulocytes were 
enriched using an adapted protocol (28, 29) and reticulocytemia assessed by microscopy. 
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Parasite lines and maintenance. P. knowlesi parasite cultures were derived from a frozen in vivo 
stabilate (A1, dated July 22 1975) supplied by Dr Louis Miller, National Institutes of Health and 
obtained following passage in vivo in rhesus macaque of the P. knowlesi H-strain derived from a 
clinical infection (23). A1-O is a non-clonal cultured line from the A1 stabilate propagated in 
cynomolgus RBCs in vitro for less than 2 months. A1-H is a non-clonal line derived from A1-O 
following maintenance in 80% human and 20% cynomolgus RBCs for 10 months and up to 7 months 
in human RBCs alone, with clones A1-H.1, A1-H.2 and A1-H.3 derived at this time. P. knowlesi A1-C is 
a non-clonal line derived from A1-O after maintenance in 100% cynomolgus RBCs for 15 months, 
with clones A1-C.1 and A1-C.2 derived at this time. Parasites were grown and synchronized as 
described previously (21). 
P. knowlesi Genome Sequencing, Analysis and De Novo Assembly. DNA for the A1-H.1 and A1-C.2 
lines was used for preparation of libraries: HiSeq 2000 (Illumina Inc. USA) compatible genomic 
shotgun libraries (500 bp fragment size), PCR-free libraries sequenced on MiSeq (Illumina) and for 
genome assemblies, 20 kbp insert libraries sequenced on a PacBio RS-II instrument (Pacific 
Biosciences Inc.). Genome assembly was performed using PacBio's FALCON tools, and Genome 
Consensus suite. Annotation was transferred from the P. knowlesi H strain reference genome (24) 
and gene models were checked in Artemis BAM view and corrected using strand-specific RNA-seq 
datasets.  
Antibody production. The mouse P. knowlesi MSP133-specific antibody has been described (27). A P. 
knowlesi MSP119-specific antibody was produced following rabbit immunization with recombinant 
MSP119. Rat anti-human RBC ghost antibody was prepared using A+ human erythrocytes  and the 
resulting antiserum used for immunolabeling both human and cynomolgus RBC due to cross 
reactivity. 
Adhesion, invasion and growth assays. Purified schizonts were used to set up triplicate cultures 
with cynomolgus, rhesus, human or human reticulocyte-enriched RBCs,  at a 2% hematocrit and a 
1% parasitemia.  All parasites (including A1-H.1) were grown in cynomolgus RBCs for at least one 
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month prior to growth assays, to control for any effect of prior host cell type on subsequent invasion 
and growth. Parasitemia was measured with a flow cytometry (FACS)-based assay (21, 26) at the 
start and following incubation at 37oC in a gassed chamber for 7 h, 24 h and 48 h. Samples were 
fixed , washed, permeabilized  with Triton® X-100, and then washed again prior to RNAse treatment, 
staining with SYBR® Green I (Life Technologies) and FACS analysis. To control for invasion of RBCs 
carried over during schizont purification, target cells were pre-labelled with a far red fluorescence 
dye (26) using 7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacridin-2-one) succinimidyl ester (DDAO-SE) 
(Life Technologies). Following washing the samples were analyzed on a CyAN ADP Analyzer 
(Beckman Coulter). Data were acquired and analysed using CellQuest (BD) or HyperCyt (Beckman 
Coulter) software. 
To investigate invasion/binding phenotype and reticulocyte preference, samples taken  at 7 
h were incubated with reticulocyte stain solution (Sigma), then the cells were pelleted and Giemsa-
stained thin blood films prepared.  To attempt to readapt ΔNBPXa parasites to growth in human 
RBC, a culture at 1% parasitemia was set up and maintained for 1 month. After parasites were no 
longer detectable in blood smears (4 days), the culture was maintained by replacement with 30% 
fresh human RBCs and medium every 2-3 days. The (revertant) parasites that were detectable after 
28 days were analysed by PCR together with A1-H.1 and ΔNBPXa controls. 
The difference between adhesion and invasion of merozoites was also measured using an 
immunofluorescence assay. Synchronous P. knowlesi A1-H.1 or ΔNBPXa schizonts were added to 
triplicate cultures at 2% parasitemia with cynomolgus or human RBC and after 3 h thin blood films 
were prepared for immunofluorescence staining.  The number of free merozoites (MSP119 positive, 
MSP133 positive, no contact with RBC), attached merozoites (MSP119 positive, MSP133 positive, in 
contact with RBCs), rings (MSP119 positive, MSP133 negative, within RBCs) and RBCs were counted. A 
minimum of 1000 RBCs was examined.  
DNA constructs and PCR . The DNA construct (NBPXa_1XKO ) for targeted disruption of NBPXa 
(GeneDB ID PKNH_1472300) via single cross over homologous recombination was adapted from a 
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precursor to the PkconGFPep vector (21) and used a 1.2 kb region of the 5’ end of the NBPXa gene to 
target the NBPXa locus, with  linearization for transfection using the BsiWI site situated in the NBPXa 
fragment.   
Transfection, cloning and genotyping. Parasites were transfected  with NBPXa_1XKO or positive 
control plasmid PkconGFPp230p (21) and fresh human or cynomolgus RBCs added every 4 days until 
parasites were visible. Parasites were cloned by limiting dilution, a process requiring 9 or 14 days in 
either cynomolgus or human RBC respectively, and then expanded for genotypic and phenotypic 
analysis. Transfected parasites were analysed by diagnostic PCR with two different primer sets. The 
first was designed to amplify a 1,478 bp fragment only from the intact wild type NBPXa locus (ol1 
and ol2) and the second was designed to amplify a 1,306 bp fragment after correct integration of 
NBPXa_1XKO (ol1 and ol3). PCR reactions were carried out using GoTaq Mastermix (Promega) using 
the following cycle conditions: 3 min at 96 °C, then 30 cycles of 25 s at 96 °C, 25 s at 52 °C, and 2 min 
at 64 °C, and a final extension of 5 min at 64 °C.  
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Figure Legends 
Figure 1: Genomic comparisons of adapted parasite lines. (A) Genomic differences across 
Plasmodium knowlesi lines and derived clones used in this study. Starting material was the A1 
stabilate derived from the H strain grown in a rhesus macaque. Schematic shows SNPs (green) and 
small INDELs (blue) identified between the H strain, the original A1-O line and human RBC-adapted 
A1-H and cynomolgus RBC-adapted A1-C lines, and respective clones. Venn diagrams show the 
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relationship among A1-O, A1-H, and A1-C to the genome of a clone from each line.  The presence of 
the known invasion genes in the clones (A1-H.1 to H.3, and A1-C.1 to C.2) is shown. (B) Mapping 
Illumina reads coverage of P. knowlesi A1-O (green), A1-C (red) and A1-H (blue) against chromosome 
14 of P. knowlesi H viewed in Artemis . The highlighted area shows the lack of A1-C read coverage, 
corresponding to a 66.3 kbp deletion encompassing the invasion-related gene NBPXa 
(PKNH_1472300). 
 
Figure 2: Phenotypic characterisation of the A1-O parasite line. (A) Growth of the A1-O line and the 
long-term culture adapted A1-C.1 and A1-H.1 clones in cynomolgus or human RBCs after 24 h (a 
mean of 4 independent experiments +/- 1 SD). Statistical significance determined using a two factor 
ANOVA with Sidak post hoc test to provide multiplicity adjusted p-values. Significant (*) and non-
significant (ns) results are denoted. In cynomolgus RBCs both A1-C.1 (p=0.0040) and A1-H.1 
(p=0.0021) lines grew significantly better than A1-O. In human RBCs only A1-H.1 (p=0.0285) showed 
increased growth rate relative to A1-O; in contrast A1-C.1 demonstrated a non-significant, but 
consistent, reduction in growth relative to A1-O in human RBCs. Parasitemia was determined after 
invasion (at 7 h) and after a cycle of intracellular growth (at 24 h) in either (B) cynomolgus or (C) 
human RBCs revealing that growth rates were determined by invasion efficiency and not through 
differences in subsequent intracellular growth (means of triplicate data points from a single 
experiment +/- 1 SD). 
 
Figure 3: Disruption of NBPXa can be achieved when parasites are grown in macaque RBCs, but 
not in human RBCs. (A) Disruption of NBPXa by introduction of linearised pNBPXa_1XKO into the 
genome via integration at the 5’ end of the NBPXa locus within a targeting region (hatched box). 
Primers for diagnostic analysis are indicated (thick black arrows). (B) PCR analysis of independently 
transfected parasites grown in human (T1 toT3) or cynomolgus (T1 toT5) RBCs, and two independent 
clones derived from the latter (T1.1 and T2.1), confirmed correct integration only for parasites 
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grown in cynomolgus RBCs. Panels show amplification of a product from wild type NBPXa (top panel, 
primers ol1 and ol2) and a species that can be produced only following integration (lower panel, 
primers ol1 and ol3).  
 
Figure 4: Disruption of NBPXa prevents multiplicative growth in human RBCs through impaired 
invasion.  (A) Growth of A1-C.1, A1-H.1 and ΔNBPXa in cynomolgus or human RBCs after 24 h (mean 
of 4 independent experiments +/- 1 SD). Statistical significance determined using a two factor 
ANOVA with Sidak post hoc test to provide multiplicity adjusted p-values.  Significant (*) and non-
significant (ns) results are shown. Compared to A1-H.1, ΔNBPXa showed no significant difference in 
growth in cynomolgus, but a significant reduction in human RBCs (p=0.0481). There was no 
significant growth difference of ΔNBPXa and A1-C.1 in either human or cynomolgus RBCs. Parasite 
growth and invasion over two cycles in either (B) cynomolgus or (C) human RBCs revealed a growth 
defect at or around invasion (means of triplicate data points from a single experiment +/- 1 SD). Light 
microscopic images of Giemsa-stained thin blood films from (D) A1-H.1 and (E) ΔNBPXa parasites in 
human RBCs at 7 h: newly formed rings (black arrowheads); attached but uninvaded merozoites (red 
arrowheads). Scale bar, 5µm. 
 
Figure 5: ΔNBPXa parasites attach to human RBC but fail to invade. (A) A1-H.1 and ΔNBPXa 
schizonts were purified and released merozoites were allowed to invade human or cynomolgus RBCs 
for 3 h. Panels show blood smears stained with anti-MSP133 (green), anti-MSP119 (red) and a merge 
of both MSP1 antibodies with anti-human RBC (magenta) and DAPI (blue). MSP1 is processed during 
invasion with MSP133 being shed and MSP119 retained, distinguishing external attached merozoites 
(MSP133 and MSP119 positive) from those that had successfully invaded to form rings (MSP119 only 
positive). Whilst A1-H.1 merozoites (top panel) were able to invade human RBC and form rings 
(white arrows), most ΔNBPXa merozoites (bottom panel) attached but did not invade human RBC 
(white arrowheads). Scale bar, 10µm. (B) Parasite stages present in the immunofluorescence assays 
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were quantified and graph shows the number of free merozoites, RBC-attached merozoites and 
rings stages expressed as a percentage of total merozoite-derived forms counted (means of triplicate 
cultures from a single experiment +/- 1 SD). The number in brackets indicates the average ring stage 
parasitemia for each of the parasite/blood combinations.  
 
